Simplex Trading’s Purple Biotech PPBT Stock Holding History

Simplex Trading’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-90	Closed	-$4K	–	9400
2024 Q4	$4K	Buy	+90	New	+$3.46K	﹤0.01%	7776
2023 Q2	–	Sell	-50	Closed	-$17K	–	9724
2023 Q1	$17K	Sell	50 -116	-70%	-$43.5K	﹤0.01%	7081
2022 Q4	$45K	Buy	166 +88	+113%	+$33.8K	﹤0.01%	6013
2022 Q3	$31K	Buy	+78	New	+$36.5K	﹤0.01%	7035
2022 Q2	–	Sell	-35	Closed	-$27K	–	10844
2022 Q1	$27K	Sell	35 -295	-89%	-$190K	﹤0.01%	7902
2021 Q4	$256K	Buy	330 +216	+189%	+$184K	﹤0.01%	4809
2021 Q3	$111K	Buy	114 +1	+0.9%	+$969	﹤0.01%	6469
2021 Q2	$110K	Buy	113 +112	+11,200%	+$103K	﹤0.01%	6594
2021 Q1	$43K	Buy	+1	New	+$933	﹤0.01%	6783

Other funds holding PPBT

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $240M AUM

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Simplex Trading's PPBT Position: Q1 2026 in Review

Simplex Trading reduced its Purple Biotech (PPBT) stake by 35% in Q1 2026, selling an estimated $1.76K and leaving 597 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #8302.

Simplex Trading first reported a position in PPBT in Q4 2020 and has held it in 13 quarters since. The position peaked at $34K in Q1 2023. 15 funds tracked by Wall St. Rank hold PPBT as of Q1 2026.

Simplex Trading held 597 shares of Purple Biotech worth $2.41K as of Q1 2026.
Simplex Trading sold 326 Purple Biotech shares in Q1 2026, an estimated $1.76K.
Purple Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8302 holding.
Simplex Trading first reported a position in Purple Biotech in Q4 2020 and has held it in 13 quarters since.
Simplex Trading's Purple Biotech position peaked at $34K in Q1 2023.
15 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.